<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Fibrinolytic and antithrombotic therapy</title>
    <subTitle>theory, practice, and management</subTitle>
  </titleInfo>
  <name type="personal">
    <namePart>Becker, Richard C.</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Spencer, Fredrick A.</namePart>
    <namePart type="termsOfAddress">MD</namePart>
  </name>
  <name type="corporate">
    <namePart>ebrary, Inc</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <genre authority="local">Electronic books.</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">enk</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Oxford</placeTerm>
    </place>
    <place>
      <placeTerm type="text">New York</placeTerm>
    </place>
    <publisher>Oxford University Press</publisher>
    <dateIssued>2006</dateIssued>
    <edition>2nd ed.</edition>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">electronic</form>
    <form authority="gmd">electronic resource</form>
    <extent>x, 410 p. : ill.</extent>
  </physicalDescription>
  <tableOfContents>Historical perspectives in hemostasis, coagulation and fibrinolysis -- Vascular biology, thromboresistance and inflammation -- Atherosclerosis and arterial thrombosis -- Venous thromboembolism -- Cardiac chamber, aortic and valvular thromboembolism -- Fibrinolytic agents -- Aspirin -- Clopidogrel -- Platelet Glycoprotein IIb/IIIa receptor antagonists -- Aggrenox and cilostazol -- Novel platelet antagonists --</tableOfContents>
  <tableOfContents>Combination pharmacotherapy -- Facilitated percutaneous coronary intervention -- Thrombin-directed therapy -- Factor Xa inhibitors -- Direct thrombin inhibitors -- Novel anticoagulants -- Acute coronary syndromes -- Peripheral vascular disease and stroke -- Valvular heart disease and atrial fibrillation -- Plaque-stabilizing therapies --</tableOfContents>
  <tableOfContents>Venous thromboembolism prophylaxis -- Venous thromboembolism treatment -- Fundamentals and patient evaluation -- Platelet antagonists -- Anticoagulants -- Anticoagulation clinics and self-testing -- Platelet antagonists -- Anticoagulants -- Fibrinolytic agents.</tableOfContents>
  <note type="statement of responsibility">Richard C. Becker, Frederick A. Spencer.</note>
  <note>Includes bibliographical references and index.</note>
  <note>Electronic reproduction. Palo Alto, Calif. : ebrary, 2013. Available via World Wide Web. Access may be limited to ebrary affiliated libraries.</note>
  <subject authority="lcsh">
    <topic>Thrombolytic therapy</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Fibrinolytic agents</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Thrombosis</topic>
    <topic>Treatment</topic>
  </subject>
  <classification authority="lcc">RC694.3 .B39 2006eb</classification>
  <classification authority="ddc" edition="22">616.1/3506</classification>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="isbn" invalid="yes"/>
  <identifier type="lccn" invalid="yes"/>
  <identifier type="uri">http://site.ebrary.com/lib/rucke/Doc?id=10375127</identifier>
  <location>
    <url>http://site.ebrary.com/lib/rucke/Doc?id=10375127</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">CaPaEBR</recordContentSource>
    <recordCreationDate encoding="marc">050504</recordCreationDate>
    <recordIdentifier source="CaPaEBR">ebr10375127</recordIdentifier>
  </recordInfo>
</mods>
